Journal
JOURNAL OF PEDIATRICS
Volume 148, Issue 3, Pages 332-336Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jpeds.2005.09.003
Keywords
-
Categories
Funding
- NCRR NIH HHS [M01 RR000032] Funding Source: Medline
- NIAID NIH HHS [P01 AI143681, P01 AI043681, T32 AI052069] Funding Source: Medline
- PHS HHS [M01 R00032] Funding Source: Medline
Ask authors/readers for more resources
Objective To define hearing outcomes in children with congenital cytomegalovirus (CMV) infection born to mothers with non-primary CMV infection. Study design A cohort of 300 children with congenital CMV infection identified by newborn virologic screening at the University of Alabama Hospital and a private community hospital in which the type of maternal infection could be classified constituted the study population. Maternal infections were categorized by analyzing serum samples. Children were followed prospectively and underwent serial audiologic evaluations. Results The frequency of hearing loss was not different between children born to mothers with non-primary infection (10%) and those with primary infection (11%). Significantly more children in the primary infection group had progressive and severe/profound hearing loss compared with children in the non-primary group. The frequency of bilateral, delayed onset, high-frequency, and fluctuating hearing loss was not different between the 2 groups. The mean age of diagnosis of hearing loss was 39 +/- 53 months for children born to mothers with non-primary infection and 13 +/- 21 months for the primary infection group (P =.16). Conclusions Maternal preexisting seroimmunity to CMV does not provide complete protection against hearing loss in infants with congenital CMV infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available